Serpin Pharma
Pre-clinicalBy selectively isolating a key portion of a natural SERPIN protein, our targeted therapeutic, known as SP16, restores balance to harmful inflammatory environments, creating an entirely new class of therapeutics for unmet medical needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.5M
About
By selectively isolating a key portion of a natural SERPIN protein, our targeted therapeutic, known as SP16, restores balance to harmful inflammatory environments, creating an entirely new class of therapeutics for unmet medical needs.
RNA & Gene Therapy
Funding History
2Total raised:$3.5M
Seed$3MJan 15, 2022
Grant$500KSep 15, 2020